Should Surgeons Target Both Outflow Pathways?

Nathan M. Radcliffe, MD, Editor, Glaucoma Physician, and Sean Ianchulev, MD, MPH, New York Eye and Ear of Mount Sinai, discuss whether addressing both trabecular and uveoscleral pathways could improve outcomes in moderate to advanced disease.

April 11, 2026
3 min

Ophthalmology Management

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

#1

New York Eye and Ear Infirmary of Mount Sinai

New York, NY
Key Differentiators
- Ophthalmology
- Glaucoma Surgery
- Biointerventional Devices
#2

Massachusetts Eye and Ear Infirmary, Harvard Medical School

Boston, MA
Key Differentiators
- Ophthalmology
- Glaucoma Surgery
- MIGS Research
#3

Bascom Palmer Eye Institute, University of Miami

Miami, FL
Key Differentiators
- Ophthalmology
- Glaucoma Surgery
- Clinical Research
#4

Wills Eye Hospital

Philadelphia, PA
Key Differentiators
- Ophthalmology
- Glaucoma Surgery
#5

Duke University Eye Center

Durham, NC
Key Differentiators
- Ophthalmology
- Glaucoma Surgery
- Translational Research

Should Surgeons Target Both Outflow Pathways?

Top Institutions in Ophthalmology

New York Eye and Ear Infirmary of Mount Sinai

Massachusetts Eye and Ear Infirmary, Harvard Medical School

Bascom Palmer Eye Institute, University of Miami

Wills Eye Hospital

Duke University Eye Center

Original Source(s)

Should Surgeons Target Both Outflow Pathways?

Related Content

Rerouting Eye Care: How AI and Telemedicine Are Reshaping Ophthalmology Patient Journeys in the United Kingdom and Germany

Rethinking UK Glaucoma Care

Understanding Knowledge, Attitudes, and Self-Care Practices Related to Glaucoma Among Healthcare Professionals in a Tertiary Hospital in South-South Nigeria